An open label single arm clinical study to evaluate the efficacy of Migraine-XS tablet in Migraine

M Global Nutraceuticals0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年3月6日

试验速览

暂无简介。

•1.Subjects of either sex
•2.Age 18-65 years (both inclusive)
•3.People who have severe pain at half portion of their head.
•4.If female of childbearing potential, must be willing to practice an acceptable form of birth control for the duration of the study.
•5.Are able to give written informed consent in a manner approved by the Institutional Ethics Committee and comply with the requirements of the study.
•6.Are willing to avoid participation in any other interventional clinical trial for the duration of this study.
•7.Are willing to refrain from using any lotions, gel, balm, other than those issued as part of the study, on the treatment areas during the treatment period.

•1.Are pregnant, breast-feeding, or planning to become pregnant during the study.
•2.Cluster headache patients(its different from migraine)
•3.Have participated in any interventional clinical trial in the previous 30 days.
•4.Have a known sensitivity to any of the constituents of the test products .
•5.Have a history of alcohol or illegal drug/substance abuse, or suspected alcohol or illegal drug/substance abuse in the past 2 years.

发起方

M Global Nutraceuticals